Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Zarr

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Virology|December 3, 2014
Stoichiometric parameters of HIV-1 entryMelissa Zarr, Robert Siliciano
Clinical and Translational Science|February 10, 2019
Evaluation of the Ability of Immune Humanized Mice to Demonstrate CD20-Specific Cytotoxicity Induced by OfatumumabKenrick M Semple, Carlos M Gonzaléz, Melissa Zarr, et al.
Nature Medicine|February 21, 2012
A quantitative basis for antiretroviral therapy for HIV-1 infectionBenjamin L Jilek, Melissa Zarr, Maame E Sampah, et al.
Bone Research|November 1, 2021
An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP<sup>+</sup> mononuclear cells and PDGF-BB secretionGehua Zhen, Yang Dan, Ruomei Wang, et al.
Plos One|November 3, 2015
Structural and Enzymatic Characterization of a Nucleoside Diphosphate Sugar Hydrolase from Bdellovibrio bacteriovorusAndres H de la Peña, Allison Suarez, Krisna C Duong-Ly, et al.
Nature Medicine|March 6, 2019
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapyJun Wang, Jingwei Sun, Linda N Liu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Virology|December 3, 2014
Stoichiometric parameters of HIV-1 entryMelissa Zarr, Robert Siliciano
Clinical and Translational Science|February 10, 2019
Evaluation of the Ability of Immune Humanized Mice to Demonstrate CD20-Specific Cytotoxicity Induced by OfatumumabKenrick M Semple, Carlos M Gonzaléz, Melissa Zarr, et al.
Nature Medicine|February 21, 2012
A quantitative basis for antiretroviral therapy for HIV-1 infectionBenjamin L Jilek, Melissa Zarr, Maame E Sampah, et al.
Bone Research|November 1, 2021
An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP<sup>+</sup> mononuclear cells and PDGF-BB secretionGehua Zhen, Yang Dan, Ruomei Wang, et al.
Plos One|November 3, 2015
Structural and Enzymatic Characterization of a Nucleoside Diphosphate Sugar Hydrolase from Bdellovibrio bacteriovorusAndres H de la Peña, Allison Suarez, Krisna C Duong-Ly, et al.
Nature Medicine|March 6, 2019
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapyJun Wang, Jingwei Sun, Linda N Liu, et al.
Pageof 1